Researchers have uncovered a surprising new role for the antioxidant glutathione in cancer progression. A study published in Nature reveals that cancer cells actively consume glutathione as a nutrient source, challenging long-held assumptions about its function in the body.

The discovery was made by a team led by Isaac Harris at the Wilmot Cancer Institute at the University of Rochester. Co-corresponding author and co-first author Fabio Hecht, along with co-first author Marco Zocchi, spearheaded the research within the Harris lab’s biomedical genetics department.

How Cancer Cells Exploit Glutathione as Fuel

Tumors often face nutrient scarcity in their surrounding environment. However, cancer cells have evolved mechanisms to acquire essential nutrients. This study highlights how glutathione, a powerful pro-tumor nutrient, is broken down and used as fuel by cancer cells.

Isaac Harris explains,

“Cancer cells and normal cells potentially use different food sources, and we discovered how cancer cells, specifically, break down this antioxidant and use it as fuel.”

The findings are significant because, until now, research on glutathione has primarily focused on its role in preventing or repairing cell damage. This study shifts the paradigm by demonstrating its ability to fuel tumor growth.

Harris adds,

“Maybe we need to re-examine the pantry that cancer relies on and look at things that we never thought could actually be used as food for tumors. There are additional complex metabolites that others are looking at, so we’re potentially opening a whole new interest into how cancer cells acquire nutrients and how to block that activity. It’s a really exciting time.”

Glutathione’s Dual Role: Health Benefits and Cancer Risks

The human body naturally produces glutathione, and it is also widely available as an antioxidant supplement. While glutathione is often marketed with pro-health claims, the National Cancer Institute has issued more nuanced and cautionary messages regarding antioxidants, nutrients, and dietary factors in relation to cancer.

Harris emphasizes the need for caution, stating,

“It’s important to understand how cancer hijacks certain substances that we may think of as harmless.”

He notes that antioxidants can sometimes act as a double-edged sword. For example, in a related study published last year in Nature, Jeevisha Bajaj, a colleague of Harris’, discovered that taurine—another antioxidant found in foods, supplements, and energy drinks—drives the growth of leukemia cells.

From Diet to Discovery: The Path to New Insights

Earlier research by the Harris team, in collaboration with Tom Campbell and Erin Campbell, explored how a whole-food plant-based diet may reduce pro-tumor fuel sources in the body. This work laid the foundation for the current study, which delves deeper into the complex relationship between antioxidants, health, and cancer.

Key Findings and Future Implications

The latest research analyzed breast tumor samples from individuals who had donated tissue to the Wilmot Cancer Institute’s Biobank. By isolating and examining the fluid inside these tumors, researchers found an abundant storage of glutathione, confirming that tumors aggressively consume it as a nutrient source.

In preclinical models of breast cancer, the team demonstrated that blocking the cancer’s ability to use glutathione slowed tumor growth. Harris suggests that this discovery may extend beyond breast cancer, as preliminary research indicates that many tumors consume glutathione.

While the study represents a significant breakthrough, Harris stresses the need for further investigation to fully understand the implications of these findings.